Orchard raises $150 mln to expand after GSK gene therapy deal
August 13, 2018 at 08:08 AM EDT
Anglo-American biotech company Orchard Therapeutics has raised a further $150 million to fund its work in gene therapy, building on earlier fundraisings worth more than $140 million.
